Regulatory T Cells in Autoimmune Diseases: Anti-Ergotypic T Cells

REFERENCES

• I.R. Cohen, The immunological homunculus and autoimmune disease. In N. Talal, (ed.), Molecular Autoimmunity, New York: Academic Press, pp. 438–453, 1991.
   Google Scholar
• S. Avrameas, Natural autoantibodies: From ‘horror autotoxicus’ to ‘gnothi seauton’, Immunol. Today, 12: 154–159, 1991. [CSA]
   PubMedGoogle Scholar
• I.R. Cohen and D.B. Young, Autoimmunity, microbial immunity and the immunological homunculus, Immunol. Today, 12: 105–110, 1991. [CSA], [CROSSREF]
   PubMedGoogle Scholar
• I.R. Cohen, The cognitive principle challenges clonal selection, Immunol. Today, 13: 441–444, 1992. [CSA], [CROSSREF]
   PubMedGoogle Scholar
• A.W. Lohse, F. Mor, N. Karin, and I.R. Cohen, Control of experimental autoimmune encephalomyelitis by T cells responding to activated T cells, Science, 244: 820–822, 1989.
   PubMed Web of Science ®Google Scholar
• F. Indiveri, B.S. Wilson, C. Russo, V. Quaranta, M.A. Pellegrino, and S. Ferrone, Ia-like antigens on human T lymphocytes: Relationship to other surface markers, role in mixed lymphocyte reactions, and structural profile, J. Immunol., 125: 2673–2678, 1980.
   PubMed Web of Science ®Google Scholar
• N.K. Damle and S. Gupta, Autologous mixed lymphocyte reaction in man. V. Functionally and phenotypically distinct human T-cell subpopulations respond to non-T and activated T cells in AMLR, Scand. J. Immunol., 16: 59–68, 1982.
   Google Scholar
• C. Russo, F. Indiveri, V. Quaranta, G.A. Molinaro, M.A. Pellegrino, and S. Ferrone, Stimulation of human T lymphocytes by PHA-activated autologous T lymphocytes: Analysis of the role of Ia-like antigens with monoclonal antibodies, Immunogenetics, 12: 267–274, 1981. [CROSSREF]
   Google Scholar
• B. Bergholtz, D. Albrechtsen, and E. Thorsby, Stimulation of T lymphocytes by autologous non-T lymphoid cells. Participation of HLA-D? Tissue Antigens, 10: 27–38, 1977.
   PubMed Web of Science ®Google Scholar
• H.S. Ko, S.M. Fu, R.J. Winchester, D.T. Yu, and H.G. Kunkel, Ia determinants on stimulated human T lymphocytes. Occurrence on mitogen- and antigen-activated T cells, J. Exp. Med., 150: 246–255, 1979. [CROSSREF]
   PubMed Web of Science ®Google Scholar
• S. Gupta, S. Fikrig, and E. Orti, Autologous mixed lymphocyte reaction in man. VI. Deficiency of autologous mixed lymphocyte reaction in type I (insulin-dependent) diabetes mellitus, J. Clin. Lab Immunol., 11: 59–62, 1983. [CSA]
   PubMedGoogle Scholar
• G.W. Canonica, R. Croci, M. Bagnasco, S. Ferrini, M.E. Cosulich, O. Ferrini, and G. Giordano, Deficiency of the autologous mixed lymphocyte reaction in patients with autoimmune thyroid disease, Int. Arch. Allergy Appl. Immunol., 73: 137–140, 1984. [CSA]
   PubMedGoogle Scholar
• M. Bagnasco, G. Ciprandi, A. Orlandini, G. Torre, G.W. Canonica, and G. Giordano, Autologous mixed lymphocyte reaction in Graves' disease: Relationship to clinical status, Acta Endocrinol. (Copenhagen), 110: 366–372, 1985. [CSA]
   PubMedGoogle Scholar
• D.A. Hafler, M. Buchsbaum, and H.L. Weiner, Decreased autologous mixed lymphocyte reaction in multiple sclerosis, J. Neuroimmunol., 9: 339–347, 1985. [CROSSREF]
   PubMed Web of Science ®Google Scholar
• R.L. Hirsch, Defective autologous mixed lymphocyte reactivity in multiple sclerosis, Clin. Exp. Immunol., 64: 107–113, 1986.
   PubMed Web of Science ®Google Scholar
• A. Ben-Nun, H. Wekerle, and I.R. Cohen, Vaccination against autoimmune encephalomyelitis with T-lymphocyte line cells reactive against myelin basic protein, Nature, 292, 60–61, 1981. [CROSSREF]
   PubMed Web of Science ®Google Scholar
• J. Holoshitz, Y. Naparstek, A. Ben-Nun, and I.R. Cohen, Lines of T lymphocytes induce or vaccinate against autoimmune arthritis, Science, 219: 56–58, 1983.
   PubMed Web of Science ®Google Scholar
• R. Maron, R. Zerubavel, A. Friedman, and I.R. Cohen, T lymphocyte line specific for thyroglobulin produces or vaccinates against autoimmune thyroiditis in mice, J. Immunol., 131: 2316–2322, 1983.
   PubMed Web of Science ®Google Scholar
• K. Kakimoto, M. Katsuki, T. Hirofuji, H. Iwata, and T. Koga, Isolation of T cell line capable of protecting mice against collagen-induced arthritis, J. Immunol., 140: 78–83, 1988.
   PubMed Web of Science ®Google Scholar
• W.A. Taylor and R.A. Hughes, Responsiveness to P2 of blood- and cauda equina-derived lymphocytes in experimental allergic neuritis in the Lewis rat: Preliminary characterisation of a P2-specific cauda equina-derived T cell line, J. Neuroimmunol., 19: 279–289, 1988. [CROSSREF]
   PubMedGoogle Scholar
• I.R. Cohen, Regulation of autoimmune disease physiological and therapeutic, Immunol. Rev., 94: 5–21, 1986.
   PubMed Web of Science ®Google Scholar
• I.R. Cohen, T-cell vaccination for autoimmune disease: A panorama, Vaccine, 20: 706–710, 2001. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• O. Lider, T. Reshef, E. Beraud, A. Ben-Nun, and I.R. Cohen, Anti-idiotypic network induced by T cell vaccination against experimental autoimmune encephalomyelitis, Science, 239: 181–183, 1988.
   PubMed Web of Science ®Google Scholar
• D. Sun, Y. Qin, J. Chluba, J.T. Epplen, and H. Wekerle, Suppression of experimentally induced autoimmune encephalomyelitis by cytolytic T-T cell interactions, Nature, 332: 843–845, 1988. [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Y. Naparstek, A. Ben-Nun, J. Holoshitz, T. Reshef, A. Frenkel, M. Rosenberg, and I.R. Cohen, T lymphocyte lines producing or vaccinating against autoimmune encephalomyelitis (EAE). Functional activation induces peanut agglutinin receptors and accumulation in the brain and thymus of line cells, Eur. J. Immunol., 13: 418–423, 1983.
   PubMed Web of Science ®Google Scholar
• A.W. Lohse, T.W. Spahn, T. Wolfel, J. Herkel, I.R. Cohen, and K.H. Meyer zum Buschenfelde, Induction of the anti-ergotypic response, Int. Immunol., 5: 533–539, 1993.
   PubMed Web of Science ®Google Scholar
• S.A. Brod, M. Purvee, D. Benjamin, and D.A. Hafler, T-T cell interactions are mediated by adhesion molecules, Eur. J. Immunol., 20: 2259–2268, 1990. [CSA]
   PubMed Web of Science ®Google Scholar
• R. Ware, H. Jiang, N. Braunstein, J. Kent, E. Wiener, B. Pernis, and L. Chess, Human CD8+ T lymphocyte clones specific for T cell receptor V beta families expressed on autologous CD4+ T cells, Immunity, 2: 177–184, 1995. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• F. Mor, B. Reizis, I.R. Cohen, and L. Steinman, IL-2 and TNF receptors as targets of regulatory T-T interactions: Isolation and characterization of cytokine receptor-reactive T cell lines in the Lewis rat, J. Immunol., 157: 4855–4861, 1996.
   PubMed Web of Science ®Google Scholar
• A. Mimran, F. Mor, P. Carmi, F.J. Quintana, V. Rotter, and I.R. Cohen, DNA vaccination with IL-2 receptor a-chain gene (CD25) induces an anti-ergotypic response and protects Lewis rats from adjuvant arthritis. J. Clin. Invest., 113: 924–932, 2004. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Y. Minami, T. Kono, T. Miyazaki, and T. Taniguchi, The IL-2 receptor complex: Its structure, function, and target genes, Annu. Rev. Immunol., 11: 245–268, 1993. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• T. Taniguchi, and Y. Minami, The IL-2/IL-2 receptor system: a current overview, Cell, 73: 5–8, 1993. [CROSSREF]
   PubMed Web of Science ®Google Scholar
• W. van Eden, J. Holoshitz, Z. Nevo, A. Frenkel, A. Klajman, and T.R. Cohen, Arthritis induced by a T-lymphocyte clone that responds to Mycobacterium tuberculosis and to cartilage proteoglycans, Proc. Natl. Acad. Sci. U. S. A., 82: 5117–5120, 1985.
   PubMed Web of Science ®Google Scholar
• X. Paliard, S.G. West, J.A. Lafferty, J.R. Clements, J.W. Kappler, P. Marrack, and B.L. Kotzin, Evidence for the effects of a superantigen in rheumatoid arthritis, Science, 253: 325–329, 1991.
   PubMed Web of Science ®Google Scholar
• W. van Eden, J.E. Thole, R. van der Zee, A. Noordzij, J.D. van Embden, E.J. Hensen, and I.R. Cohen, Cloning of the mycobacterial epitope recognized by T lymphocytes in adjuvant arthritis, Nature, 331: 171–173, 1988. [CROSSREF]
   PubMed Web of Science ®Google Scholar
• A. O'Garra, L. Steinman, and K. Gijbels, CD4+ T-cell subsets in autoimmunity, Curr. Opin. Immunol., 9: 872–883, 1997. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• F. Bouchonnet, D. Lecossier, A. Bellocq, I. Hamy, and A.J. Hance, Activation of T cells by previously activated T cells. HLA-unrestricted alternative pathway that modifies their proliferative potential, J. Immunol., 153: 1921–1935, 1994.
   Google Scholar
• M.H. Yuen, M.P. Protti, B. Diethelm-Okita, L. Moiola, J.F. Howard, Jr., and B.M. Conti-Fine, Immunoregulatory CD8+ cells recognize antigen-activated CD4+ cells in myasthenia gravis patients and in healthy controls, J. Immunol., 154: 1508–1520, 1995.
   Google Scholar
• D.A. Hafler, I. Cohen, D.S. Benjamin, and H.L. Weiner, T cell vaccination in multiple sclerosis: A preliminary report, Clin. Immunol. Immunopathol., 62: 307–313, 1992. [CROSSREF]
   PubMedGoogle Scholar
• J. Zhang, R. Medaer, P. Stinissen, D. Hafler, and J. Raus, MHC-restricted depletion of human myelin basic protein-reactive T cells by T cell vaccination, Science, 261: 1451–1454, 1993.
   PubMed Web of Science ®Google Scholar
• A.W. Lohse, N.P. Bakker, E. Hermann, T. Poralla, M. Jonker, and K.H. Meyer zum Buschenfelde, Induction of an anti-vaccine response by T cell vaccination in non-human primates and humans, J. Autoimmun., 6: 121–130, 1993. [CROSSREF]
   Google Scholar
• J. Correale, M. Rojany, and L.P. Weiner, Human CD8+ TCR-alpha beta(+) and TCR-gamma delta(+) cells modulate autologous autoreactive neuroantigen-specific CD4+ T-cells by different mechanisms, J. Neuroimmunol., 80: 47–64, 1997. [CROSSREF]
   PubMed Web of Science ®Google Scholar
• S.H. Kaufmann, gamma/delta and other unconventional T lymphocytes: What do they see and what do they do? Proc. Natl. Acad. Sci. U. S. A., 93: 2272–2279, 1996. [CSA], [CROSSREF]
   PubMedGoogle Scholar
• K.E. Balashov, S.J. Khoury, D.A. Hafler, and H.L. Weiner, Inhibition of T cell responses by activated human CD8+ T cells is mediated by interferon-gamma and is defective in chronic progressive multiple sclerosis, J. Clin. Invest., 95: 2711–2719, 1995.
   PubMed Web of Science ®Google Scholar
• P. Stinissen, J. Zhang, C. Vandevyver, G. Hermans, and J. Raus, Gamma/delta T cell responses to activated T cells in multiple sclerosis patients induced by T cell vaccination, J. Neuroimmunol., 87: 94–104, 1998. [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Y.C. Zang, J. Hong, M.V. Tejada-Simon, S. Li, V.M. Rivera, J.M. Killian, and J.Z. Zhang, Th2 immune regulation induced by T cell vaccination in patients with multiple sclerosis, Eur. J. Immunol., 30: 908–913, 2000. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• R.K. Gershon and K. Kondo, Cell interactions in the induction of tolerance: The role of thymic lymphocytes, Immunology, 18: 723–737, 1970.
   PubMed Web of Science ®Google Scholar
• R.K. Gershon and K. Kondo, Infectious immunological tolerance, Immunology, 21: 903–914, 1971.
   PubMed Web of Science ®Google Scholar
• G. Moller, Do suppressor T cells exist? Scand. J. Immunol., 27: 247–250, 1988.
   PubMed Web of Science ®Google Scholar
• D.R. Green and D.R. Webb, Saying the ‘S’ word in public, Immunol. Today, 14: 523–525, 1993. [CSA], [CROSSREF]
   PubMedGoogle Scholar
• T.R. Mosmann, H. Cherwinski, M.W. Bond, M.A. Giedlin, and R.L. Coffman, Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins, J. Immunol., 136: 2348–2357, 1986.
   PubMed Web of Science ®Google Scholar
• T.R. Mosmann and R.L. Coffman, TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties, Annu. Rev. Immunol., 7: 145–173, 1989. [CSA]
   PubMed Web of Science ®Google Scholar
• S. Sakaguchi, N. Sakaguchi, M. Asano, M. Itoh, and M. Toda, Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases, J. Immunol., 155: 1151–1164, 1995.
   PubMed Web of Science ®Google Scholar
• M. Asano, M. Toda, N. Sakaguchi, and S. Sakaguchi, Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation, J. Exp. Med., 184: 387–396, 1996. [CROSSREF]
   PubMed Web of Science ®Google Scholar
• C. Baecher-Allan, J.A. Brown, G.J. Freeman, and D.A. Hafler, CD4 + CD25high regulatory cells in human peripheral blood, J. Immunol., 167: 1245–1253, 2001.
   PubMed Web of Science ®Google Scholar
• W.F. Ng, P.J. Duggan, F. Ponchel, G. Matarese, G. Lombardi, A.D. Edwards, J.D. Isaacs, and R.I. Lechler, Human CD4(+)CD25(+) cells: A naturally occurring population of regulatory T cells, Blood, 98: 2736–2744, 2001. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• L.A. Stephens, C. Mottet, D. Mason, and F. Powrie, F. Human, CD4(+)CD25(+) thymocytes and peripheral T cells have immune suppressive activity in vitro, Eur. J. Immunol., 31: 1247–1254, 2001. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• L.S. Taams, J. Smith, M.H. Rustin, M. Salmon, L.W. Poulter, and A.N. Akbar, Human anergic/suppressive CD4(+)CD25(+) T cells: A highly differentiated and apoptosis-prone population, Eur. J. Immunol., 31: 1122–1131, 2001. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• M.K. Levings, R. Sangregorio, and M.G. Roncarolo, Human CD25(+)CD4(+) T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function, J. Exp. Med., 193: 1295–1302, 2001. [CROSSREF]
   PubMed Web of Science ®Google Scholar
• H. Jonuleit, E. Schmitt, M. Stassen, A. Tuettenberg, J. Knop, and A.H. Enk, Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood, J. Exp. Med., 193: 1285–1294, 2001. [CROSSREF]
   PubMed Web of Science ®Google Scholar
• D. Dieckmann, H. Plottner, S. Berchtold, T. Berger, and G. Schuler, Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood, J. Exp. Med., 193: 1303–1310, 2001. [CROSSREF]
   PubMed Web of Science ®Google Scholar
• S. Sakaguchi, Regulatory T cells: key controllers of immunologic self-tolerance. Cell, 101: 455–458, 2000. [CROSSREF]
   PubMed Web of Science ®Google Scholar
• E.M. Shevach, Regulatory T cells in autoimmunity. Annu. Rev. Immunol., 18: 423–449, 2000. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• M.G. Roncarolo, and M.K. Levings, The role of different subsets of T regulatory cells in controlling autoimmunity. Curr. Opin. Immunol., 12: 676–683, 2000. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Y. Chen, V.K. Kuchroo, J. Inobe, D.A. Hafler, and H.L. Weiner, Regulatory T cell clones induced by oral tolerance: Suppression of autoimmune encephalomyelitis, Science, 265: 1237–1240, 1994.
   PubMed Web of Science ®Google Scholar
• H. Groux, A. O'Garra, M. Bigler, M. Rouleau, S. Antonenko, J.E. de Vries, and M.G. Roncarolo, A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis, Nature, 389: 737–742, 1997. [CROSSREF]
   PubMed Web of Science ®Google Scholar
• M.K. Levings, R. Sangregorio, F. Galbiati, S. Squadrone, R. de Waal Malefyt, and M.G. Roncarolo, IFN-alpha and IL-10 induce the differentiation of human type 1T regulatory cells, J. Immunol., 166, 5530–5539, 2001.
   PubMed Web of Science ®Google Scholar
• M.G. Roncarolo, R. Bacchetta, C. Bordignon, S. Narula, and M.K. Levings, Type 1 T regulatory cells, Immunol. Rev., 182: 68–79, 2001. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• M. Papiernik, M.L. de Moraes, C. Pontoux, F. Vasseur, and C. Penit, Regulatory CD4 T cells: Expression of IL-2R alpha chain, resistance to clonal deletion and IL-2 dependency, Int. Immunol., 10: 371–378, 1998. [CROSSREF]
   PubMed Web of Science ®Google Scholar
• M. Itoh, T. Takahashi, N. Sakaguchi, Y. Kuniyasu, J. Shimizu, F. Otsuka, and S. Sakaguchi, Thymus and autoimmunity: Production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance, J. Immunol., 162: 5317–5326, 1999.
   PubMed Web of Science ®Google Scholar
• A. Mimran, F. Mor, F.J. Quintana, and I.R. Cohen, Anti-ergotypic T cells in naïve rats, J. Autoimmun., in press, 2005. [CSA]
   Google Scholar
• A.M. Thornton and E.M. Shevach, Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific, J. Immunol., 164: 183–190, 2000.
   PubMed Web of Science ®Google Scholar
• E.M. Shevach, CD4+CD25+ suppressor T cells: More questions than answers, Nat. Rev. Immunol., 2: 389–400, 2002. [CSA]
   PubMed Web of Science ®Google Scholar
• A.M. Thornton and E.M. Shevach, CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production, J. Exp. Med., 188: 287–296, 1998. [CROSSREF]
   PubMed Web of Science ®Google Scholar
• K. Nakamura, A. Kitani, and W. Strober, Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta, J. Exp. Med., 194: 629–644, 2001. [CROSSREF]
   PubMed Web of Science ®Google Scholar
• K.W. Moore, R. de Waal Malefyt, R.L. Coffman, and A. O'Garra, Interleukin-10 and the interleukin-10 receptor, Annu. Rev. Immunol., 19: 683–765, 2001. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• J.J. Letterio, and A.B. Roberts, Regulation of immune responses by TGF-beta, Annu. Rev. Immunol., 16: 137–161, 1998. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• R. Bacchetta, C. Sartirana, M.K. Levings, C. Bordignon, S. Narula, and M.G. Roncarolo, Growth and expansion of human T regulatory type 1 cells are independent from TCR activation but require exogenous cytokines, Eur. J. Immunol., 32: 2237–2245, 2002. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• I.R. Cohen, Tending Adam's Garden: Evolving the Cognitive Immune Self. London: Academic Press, 2000.
   Google Scholar
• I.R. Cohen, Discrimination and dialogue in the immune system, Semin Immunol., 12: 215–219; discussion, 257–344, 2000. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• M. Schwartz and I.R. Cohen, Autoimmunity can benefit self-maintenance, Immunol. Today, 21: 265–268, 2000. [CSA], [CROSSREF]
   PubMedGoogle Scholar